Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  ifosfamide
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-25 of 450 for your search:
Start Over
Phase II/III Pilot Combination Chemotherapy with ARA-C/VP-16/IPP plus Mesna plus Intrathecal MTX in Pediatric Patients with Recurrent Nonlymphoblastic Lymphoma (Summary Last Modified 07/90)
Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: under 18
Sponsor: NCI
Protocol IDs: NCI-85-C-62, NCI-T85-0096N, T85-0096
Phase II/III Chemotherapy with IPP plus Mesna/MTX/CF/ADR/CDDP with Surgery for Patients with Osteosarcoma or Fibrosarcoma of the Bone Who Have Had No Prior Chemotherapy (Summary Last Modified 05/90)
Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: under 25
Sponsor: NCI
Protocol IDs: SJCRH-OS-86, NCI-T86-0086D, T86-0086
Phase II/III Study of L-PAM or IPP/Mesna, Followed by Conventional Chemotherapy with VCR/CTX/ADR plus CTX/VCR/ACT-D/ADR, Surgery, and Radiotherapy, for Stage IIB/IIC/IIIA/IIIB Rhabdomyosarcoma
Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: under 18
Sponsor: NCI
Protocol IDs: SJCRH-RMS-V, NCI-T86-0152D, T86-0152
Phase III Randomized Study of CDDP/IFF vs BIP (BLEO/IFF/CDDP) in Patients with Stage IVB, Recurrent, or Persistent Squamous Cell Carcinoma of the Cervix
Phase: Phase III
Type: Treatment
Status: Completed
Age: any age
Sponsor: NCI
Protocol IDs: GOG-149, GOG-0149
Radiation Therapy Compared With Combination Chemotherapy in Treating Patients With Cancer of the Uterus
Phase: Phase III
Type: Treatment
Status: Completed
Age: 21 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000063303, GOG-0150, ECOG-G150, NCT00002546
Combination Chemotherapy in Treating Patients With Intermediate-Grade or Immunoblastic Non-Hodgkin's Lymphoma
Phase: Phase III
Type: Treatment
Status: Completed
Age: over 15
Sponsor: NCI, Other
Protocol IDs: CDR0000063574, MDA-DM-94017, NCI-T94-0040D, DM94-017, T94-0040, NCT00002565
Phase III Randomized Study of Standard-Dose MAID (Mesna/DOX/IFF/DTIC) vs Dose-Intensified MAID with G-CSF for Advanced Adult Soft Tissue Sarcoma (Summary Last Modified 12/97)
Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 to 70
Sponsor:
Protocol IDs: FRE-FNCLCC-PALSAR-93, NCI-F94-0018
Combination Chemotherapy With Bone Marrow Transplantation in Treating Men With Germ Cell Tumors
Phase: Phase III
Type: Treatment
Status: Closed
Age: 16 and over
Sponsor: Other
Protocol IDs: CDR0000063579, FRE-IT94, FRE-FNCLCC-IT94, NCI-F94-0019, NCT00002566
Surgery With or Without Chemotherapy in Treating Patients With Soft Tissue Sarcoma
Phase: Phase III
Type: Treatment
Status: Completed
Age: 16 to 69
Sponsor: Other
Protocol IDs: EORTC-62931, CAN-NCIC-SR3, SR3, NCT00002641
Phase III Randomized Study of High-Dose vs Low-Dose Docetaxel vs Standard Chemotherapy with Vinorelbine or Ifosfamide for Non-Small Cell Lung Cancer Previously Treated with Platinum-Based Chemotherapy (Summary Last Modified 08/97)
Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: MSKCC-95088, RP-56976-TAX-320, NCI-V96-0830
Surgery With or Without Combination Chemotherapy in Treating Patients With Lung Metastases From Soft Tissue Sarcoma
Phase: Phase III
Type: Treatment
Status: Completed
Age: 16 and over
Sponsor: Other
Protocol IDs: EORTC-62933, E-EORTC-62933, SSG-EORTC-62933, SWOG-EORTC-62933, NCT00002764
Start Over